ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1016 participants.

Also called NCT06608823

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,016 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06608823
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06608823. Randomized; no masking; primary purpose treatment. Start 2025-06-18 (actual); primary completion 2027-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Acronym
ARTIST
Condition
Aortic Regurgitation
Condition
Aortic Valve Insufficiency
Condition
Aortic Insufficiency
Intervention (Device)
SAVR
Lead sponsor
JenaValve Technology, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06608823
Content hash
05d8fd89b9eb3613b46b7d00f2d5d173b2e1365b5d9f1c1a48ee98e389268a9e